← Back to Search

Telehealth Smoking Cessation for Quitting Smoking (E-STOP Trial)

Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights

E-STOP Trial Summary

This trial is testing whether an electronic visit (e-visit) for smoking cessation is effective. Participants will be assigned at random to either receive the e-visit or not. The e-visit will be in the form of an online questionnaire about smoking history, motivation to quit, and preferences for quitting medications. If participants are randomized to the e-visit group, they may receive a prescription for a smoking cessation medication, but they are not required to take it. The study will last 24 weeks and consist of four time points where participants will answer questionnaires and provide breath samples.

Who is the study for?
This trial is for adults who smoke at least 5 cigarettes a day, are fluent in English, have daily email access, and own a smartphone. They must be enrolled or willing to enroll in MyChart with a valid address. It's not for those who've used FDA-approved quitting meds recently.Check my eligibility
What is being tested?
The study tests an e-visit system designed to help people quit smoking against the usual treatment methods. Participants will either receive this innovative online support tool or continue with standard care without the e-visit intervention.See study design
What are the potential side effects?
Since participants may get prescriptions for smoking cessation medications based on their e-visits, potential side effects include those associated with such medications like nausea, insomnia, headaches, dry mouth, and constipation.

E-STOP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cigarettes smoking
E-visit Acceptability
E-visit Adoption
+3 more

E-STOP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Smoking cessation electronic visit (e-visit)Experimental Treatment1 Intervention
This group will be sent 1) an invitation to complete an electronic visit (e-visit) focused on cigarette smoking and 2) an invitation to complete a follow-up e-visit one-month after the initial e-visit.
Group II: Treatment as usual (TAU)Active Control1 Intervention
This group will be provided information about the state quitline and about the importance of quitting smoking and it will be recommended that they contact their PCP to schedule a medical visit to discuss quitting smoking.
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking cessation e-visit

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,932,995 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
932 Previous Clinical Trials
7,393,718 Total Patients Enrolled

Media Library

Smoking cessation e-visit Clinical Trial Eligibility Overview. Trial Name: NCT05493254 — N/A
Smoking Cessation Research Study Groups: Smoking cessation electronic visit (e-visit), Treatment as usual (TAU)
Smoking Cessation Clinical Trial 2023: Smoking cessation e-visit Highlights & Side Effects. Trial Name: NCT05493254 — N/A
Smoking cessation e-visit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05493254 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial still being accepted?

"This research initiative, published on August 31st 2022, is still recruiting participants. The information was recently updated on November 15th 2022."

Answered by AI

What is the upper-limit of individuals involved in this research?

"Correct. According to the clinicaltrials.gov, this medical examination is actively looking for participants since its introduction on August 31st 2022 and most recent update in November 15th 2022. A total of 672 patients are required across one location."

Answered by AI

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

Id really like to quit smoking. I been smoking 43 years I need help quitting.
PatientReceived no prior treatments
~414 spots leftby Dec 2026